171 related articles for article (PubMed ID: 17979137)
21. [Immune monitoring of kidney transplant recipients: can markers predictive of over-immunosuppression be identified?].
Saas P; Courivaud C; Bamoulid J; Garnache-Ottou F; Seilles E; Ducloux D
Ann Pharm Fr; 2008 Mar; 66(2):115-21. PubMed ID: 18570910
[TBL] [Abstract][Full Text] [Related]
22. AKT1 leader gene and downstream targets are involved in a rat model of kidney allograft tolerance.
Jovanovic V; Giacomelli L; Sivozhelezov V; Degauque N; Lair D; Soulillou JP; Pechkova E; Nicolini C; Brouard S
J Cell Biochem; 2010 Oct; 111(3):709-19. PubMed ID: 20607729
[TBL] [Abstract][Full Text] [Related]
23. Immune modulation and graft protection by gene therapy in kidney transplantation.
Sandovici M; Deelman LE; de Zeeuw D; van Goor H; Henning RH
Eur J Pharmacol; 2008 May; 585(2-3):261-9. PubMed ID: 18410915
[TBL] [Abstract][Full Text] [Related]
24. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
25. Microarrays: interrogating the transplant transcriptosome.
Shah S; Sarwal MM
Clin Transpl; 2004; ():261-7. PubMed ID: 16704157
[TBL] [Abstract][Full Text] [Related]
26. Microarrays: a monitoring tool for transplant patients?
Weintraub LA; Sarwal MM
Transpl Int; 2006 Oct; 19(10):775-88. PubMed ID: 16961768
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
28. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
29. [New diagnostic tools in renal transplantation].
Thervet E; Legendre C
Nephrol Ther; 2006 Sep; 2(4):165-75. PubMed ID: 16966061
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
Scherer A; Gwinner W; Mengel M; Kirsch T; Raulf F; Szustakowski JD; Hartmann N; Staedtler F; Engel G; Klupp J; Korn A; Kehren J; Haller H
Nephrol Dial Transplant; 2009 Aug; 24(8):2567-75. PubMed ID: 19398767
[TBL] [Abstract][Full Text] [Related]
32. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective.
Demetris AJ; Lunz JG; Randhawa P; Wu T; Nalesnik M; Thomson AW
Transpl Int; 2009 Jan; 22(1):120-41. PubMed ID: 18980624
[TBL] [Abstract][Full Text] [Related]
33. Steroid-free immunosuppression in kidney transplant recipients: the University of Minnesota experience.
Humar A; Dunn T; Kandaswamy R; Payne WD; Sutherland DE; Matas AJ
Clin Transpl; 2007; ():43-50. PubMed ID: 18637457
[TBL] [Abstract][Full Text] [Related]
34. A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation.
Roedder S; Li L; Alonso MN; Hsieh SC; Vu MT; Dai H; Sigdel TK; Bostock I; Macedo C; Metes D; Zeevi A; Shapiro R; Salvatierra O; Scandling J; Alberu J; Engleman E; Sarwal MM
J Am Soc Nephrol; 2015 Aug; 26(8):2042-53. PubMed ID: 25429124
[TBL] [Abstract][Full Text] [Related]
35. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
[TBL] [Abstract][Full Text] [Related]
36. Impact of endotoxin exposure after exhausting exercise on the immune system in solid organ transplant recipients.
Königsrainer I; Löffler M; Bühler S; Walter M; Schafbuch L; Beckert S; Glatzle J; Horvath P; Northoff H; Nadalin S; Königsrainer A; Zieker D
Exerc Immunol Rev; 2012; 18():177-83. PubMed ID: 22876728
[TBL] [Abstract][Full Text] [Related]
37. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
38. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity.
Heldal K; Hartmann A; Leivestad T; Svendsen MV; Foss A; Lien B; Midtvedt K
Transplantation; 2009 Apr; 87(7):1045-51. PubMed ID: 19352126
[TBL] [Abstract][Full Text] [Related]
40. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
